연구성과로 돌아가기
2021 연구성과별 연구자 정보 (182 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Anticancer effects of 6-shogaol via the AKT signaling pathway in oral squamous cell carcinoma | Huang, Hai | Huang, H | 1 | Kyungpook Natl Univ, Dept Anim Sci & Biotechnol, 2559 Gyeongsang Daero, Sangju 37224, South Korea | 0000-0002-1811-9232 | HUANG, HAI | ok4325@knu.ac.kr;rim0804@knu.ac.kr; | |||
| Anticancer effects of 6-shogaol via the AKT signaling pathway in oral squamous cell carcinoma | Kim, Myoung-Ok | Kim, MO | 2 | 교신저자 | Kyungpook Natl Univ, Dept Anim Sci & Biotechnol, 2559 Gyeongsang Daero, Sangju 37224, South Korea | ok4325@knu.ac.kr;rim0804@knu.ac.kr; | ||||
| Anticancer effects of 6-shogaol via the AKT signaling pathway in oral squamous cell carcinoma | Kim, Ki-Rim | Kim, KR | 3 | 교신저자 | Kyungpook Natl Univ, Dept Dent Hyg, 2559 Gyeongsang Daero, Sangju 37224, South Korea | 0000-0002-5967-6537 | Kim, Ki-Rim | ok4325@knu.ac.kr;rim0804@knu.ac.kr; | ||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Jeon, In Seon | Jeon, IS | 1 | Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Jeon, In Seon | Jeon, IS | 1 | Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 Plus KNU Biomed Convergence Program, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Jeon, In Seon | Jeon, IS | 1 | Kyungpook Natl Univ, Sch Med, CMRI, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Yoo, Jae Do | Yoo, JD | 2 | Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Yoo, Jae Do | Yoo, JD | 2 | Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 Plus KNU Biomed Convergence Program, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Yoo, Jae Do | Yoo, JD | 2 | Kyungpook Natl Univ, Sch Med, CMRI, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Gurung, Smriti | Gurung, S | 3 | Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Gurung, Smriti | Gurung, S | 3 | Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 Plus KNU Biomed Convergence Program, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Kim, Minseong | Kim, M | 4 | Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Kim, Minseong | Kim, M | 4 | Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, BK21 Plus KNU Biomed Convergence Program, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Kim, Minseong | Kim, M | 4 | Kyungpook Natl Univ, Sch Med, CMRI, 680 Gukchaebosang Ro, Daegu 41944, South Korea | soyounki@knu.ac.kr; | |||||
| Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs | Lee, Chanju | Lee, C | 5 | Natl Canc Ctr, Grad Sch Canc Sci & Policy, Div Canc Biomed Sci, Canc Immunol Branch, Goyang 10408, South Korea | 0000-0001-9356-3432 | Lee, Chanju | soyounki@knu.ac.kr; |
페이지 이동: